In a study done on 73 patients diagnosed with locally advanced rectal adenocarcinoma, the expression levels of FAK were significantly lower in non-responders when compared to responders (p = 0.007) [42]. The gene discussed is PTK2; the disease is rectum adenocarcinoma.